Neurology® Podcast

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Richard Dubinsky about his paper on transcutaneous electric nerve stimulation. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about neuroacanthocytosis can mimic Huntington disease. The next part of the podcast is excerpts from an AANEM interview with Dr. Ray Adams along with a brief introduction from Dr. Ted Burns. Theres a book review about Dr. Ray Adams in this weeks issue of Neurology. Please be sure to check out the review of the book, which is titled: Raymond Adams. A life of mind and muscle by Dr. Peter J. Koehler. The participants had nothing to disclosure except Dr. Dubinsky. Dr. Dubinsky serves on a scientific advisory board and speakers bureau for Allergan, Inc.; receives honoraria from BrioMed; receives research support from Allergan, Inc., Merz Pharmaceuticals GmbH, and the NIH [NHGRI/NINDS #1R01HG02449-01 (Site Investigator); NIAM/NINDS #R01NS052592 (Site Investigator), NIAM/NINDS #R01NS052619-01 (Site Investigator), NIAM/NINDS #R01NS052592-01 (Site Investigator), NCCAM #2007P000827 (Site Investigator), NCCAM #UO1AT000613 (Site Investigator)]; and his spouse owns stock in Abbott.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Juliana Lockman interview Dr. Roderick Duncan about his paper on psychogenic non epileptic attacks. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about rosary-like calcifications in carotid stenosis. The next part of the podcast is Dr. Michael Benatar interviews Dr. Chris Coffey for our Lesson of the week about non-inferiority trials. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclosure except Dr. Duncan. Dr. Duncan has received speaker honoraria and funding for travel from UCB.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interview Dr. Stephen Salloway about his paper on using bapineuzumab in mild to moderate Alzheimer disease. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about the Heidenhain variant of Creutzfeldt Jakob disease. The podcast concludes where Dr. Beau Bruce interviews Dr. Brian Weinshenker for the Lesson of the Week (disease of the month) on triptans. The participants had nothing to disclose except Drs. Burns & Salloway. Dr. Burns serves on the Neurology Podcast Committee.Dr. Salloway serves on scientific advisory boards for Myriad Genetics, Inc, Elan Corporation, Sanofi-aventis, Eisai Inc., and Pfizer; serves on the editorial board of the Journal of Neuropsychiatry and Clinical Neurosciences; receives royalties from American Psychiatric Press Inc and Humana Press; received speaker honoraria from Eisai Inc., Pfizer, Novartis, Forest Laboratories, Inc. and Elan Corporation; serves as a consultant to Merck Serono and Medivation-data safety committee; receives research support from Elan Corporation, Wyeth, Bristol-Myers Squibb, Alzheimers Disease Neuroimaging Initiative, Dominantly Inherited Alzheimers Network, Aging Brain: DTI, Subcortical Ischemia and Behavior and NIH [NIA 1 R03 AGO23916-01A1]; receives funding from The Norman and Rosalie Fain Family Foundation.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Sam Taylor interview Dr. Una McCann about her paper on recreational MDMA (Ecstasy). In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about EEG for diagnosis of tick paralysis. The podcast concludes where Dr. Ted Burns provides an introduction to Dr. Mateens interview with Dr. Donald Mulder which was recorded for the January 8, 2008 Lesson of the Week. Dr. Mulders In Memoriam is published in this issue. The participants had nothing to disclose except Dr. McCann. Dr. McCann has served on a scientific advisory board and speakers bureau for Jazz Pharmaceuticals; has received honoraria from Public Health Service and the Veterans Administration (grant reviews); and receives research support from the NIH [NIDA #R01 DA010217 (PI), NHLBI/NIDA #1 R01 Hl071501 (PI), NIDA # 1RO1 DA017231-01 A1 (Co-I), NIDA #2 RO1 DA05707 (Co-I), NIDA #2 RO1 DA05938 (Co-I), and NICHHD #1 R01 HD050202-01 (Co-I).]

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interview Dr. Massimo Filippi about his paper on oral vs. intravenous methyprednisolone in MS. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about pseudo-myasthenic ptosis. The next part of the podcast is Dr. Alberto Espay interviews Dr. Josep Dalmau for our Lesson of the week toolbox about NMDAR encephalitis. The participants had nothing to disclosure except Drs. Keegan, Filippi, Espay and Dalmau. Dr. Keegan serves as Section Co-Editor for Neurology and the Neurology Podcast Panel.Dr. Filippi serves on scientific advisory boards for Teva Pharmaceutical Industries Ltd. and Genmab A/S; has received funding for travel from Bayer Schering Pharma, Biogen-Dompè AG, Genmab A/S, Merck Serono, and Teva Pharmaceutical Industries Ltd.; serves on editorial boards of the American Journal of Neuroradiology, BMC Musculoskeletal Disorders, Clinical Neurology and Neurosurgery, Erciyes Medical Journal, Journal of Neuroimaging, Journal of Neurology Neurosurgery and Psychiatry, Journal of Neurovirology, Magnetic Resonance Imaging, Multiple Sclerosis, and Neurological Sciences ; serves as a consultant to Bayer Schering Pharma, Biogen-Dompè AG, Genmab A/S, Merck Serono, Pepgen Corporation, and Teva Pharmaceutical Industries Ltd.; serves on speakers' bureaus for Bayer Schering Pharma, Biogen-Dompè AG, Genmab A/S, Merck Serono, and Teva Pharmaceutical Industries Ltd.; and receives research support from Bayer Schering Pharma, Biogen-Dompè AG, Genmab A/S, Merck Serono, Teva Pharmaceutical Industries Ltd., Fondazione Italiana Sclerosi Multipla, and Fondazione Mariani. Dr. Espay has received personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, and honoraria from UCB-SCHWARZ PHARMA AG; Medtronic, Inc. and Novartis.Dr. Dalmau has received honoraria for lectures not funded by industry; receives research support from EUROIMMUN and the NIH/NCI [RO1CA107192 (PI) and RO1CA89054-06A2 (PI)]; has received license fee payments from EUROIMMUN for an NMDA receptor autoantibody test (patent pending PCT/US07/18092, filed: August 15, 2007); and has received royalty payments and may accrue revenue for US Patent 6,387,639;, issued: May 14th, 2002: Patent for Ma2 autoantibody test.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Heather Harle interview Dr. Rod Adam about his paper on coccidioidal meningitis and brain abscesses. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about isolated medial rectus palsy in midbrain infarction. The next part of the podcast is Dr. Alberto Espay interviews Dr. Daniel Weintraub for our Lesson of the week toolbox about MoCA vs MMSE. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclosure except Drs. Espay and Weintraub. Dr. Espay has received personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, and honoraria from UCB-SCHWARZ PHARMA AG; Medtronic, Inc. and Novartis.Dr. Weintraub has served on a scientific advisory board for Boehringer Ingelheim ; serves on the editorial board of Movement Disorders; has received honoraria from Boehringer Ingelheim, ACADIA Pharmaceuticals Inc., Novartis, Osmotica Pharmaceutical Corp., BrainCells Inc., Merck Serono, Sanofi-aventis, and Pfizer Inc; and receives research support from Boehringer Ingelheim and the NIH [#K23 MH067894 (Principal Investigator)].

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Interim Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Mauermann interview Dr. Hiroshi Mitsumoto about his paper on how progressive muscular atrophy is a form of ALS. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about neuromuscular disorders unmasked by statin therapy. The podcast concludes where Dr. Beau Bruce interviews Dr. Brian Weinshenker for the Lesson of the Week (disease of the month) on neuromyelitis optica. The participants had nothing to disclose except Drs. Mitsumoto & Weinshenker. Dr. Mitsumoto has served on scientific advisory boards for and/or received speaker honoraria from Avanir Pharmaceuticals, Knopp Neurosciences Inc., Neuralstem, Inc., and Sanofi-aventis, and Otsuka Pharmaceutical Co., Ltd.; and has received research support from Avanir Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knopp Neurosciences Inc., the NIH [NINDS #R01NS04812 (Co-I) and NIEHS #1R01ES016348-01A2 (PI)], the Muscular Dystrophy Association, the ALS Association, and the MDA Wings Over Wall Street.Dr. Weinshenker serves as an editorial board members for Canadian Journal of Neurosciences and Turkish Journal of Neurology, received revenue for a patent held by Mayo Foundation licensed to RSR Limited, was a consultant for CaridianBCT in 2008, and receives research support from the Guthy-Jackson Charitable Foundation.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Interim Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Barrett interview Drs. Pablo Martinez-Martin and K. Ray Chaudhuri about their paper on non-motor symptoms scale in Parkinson disease. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about varicella zoster virus can mimic Guillain-Barre syndrome. The podcast concludes where Dr. Ted Burns interviews Dr. David Loring for the Lesson of the Week on psychometric properties. The participants had nothing to disclose except Drs. Martinez-Martin and Chaudhuri. Dr. Martinez-Martin served on a scientific advisory board for Novartis; serves on the editorial boards of Neurologia, the Spanish Society of Neurology, Revista de Neurologia, and Societies of Neurology of the Spanish autonomous regions; has received speaker honoraria from Sanofi aventis and Novartis; and receives research support from Novartis and the Carlos III Institute of Health.Dr. Chaudhuri serves on scientific advisory boards for Solvay Pharmaceuticals, Inc., Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, and Teva Pharmaceutical Industries, Ltd.; has received speaker honoraria from the European Federation of Neurological Societies, the Swedish Movement Disorders Society, and LIMPE Italy; and receives research support for a clinical research nurse from UCB.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Interim Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interview Dr. Aline Bouwes about her paper on mild hypothermia after cardiopulmonary resuscitation. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about parkinsonism-hyperpyrexia syndrome. The podcast concludes where Dr. Michael Benatar interviews Dr. Mark Conaway for the Lesson of the Week on sensitivity and specificity. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Interim Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Russ Swerdlow interview Dr. Dan Larriviere about the AAN paper on neuroenhancements. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about the Serotonin syndrome. The next part of the podcast is Dr. Alberto Espay interviews Dr. Ruth Walker for our Lesson of the week toolbox about chorea-acanthocytosis. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclosure except Drs. Larriviere, Espay and Walker. Dr. Larriviere has received honoraria for serving on the American Association for the Advancement of Science Faculty and has received an unrestricted educational grant from Allergan, Inc.Dr. Espay has received personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, and honoraria from UCB-SCHWARZ PHARMA AG; Medtronic, Inc. and Novartis.Dr. Walker has received honoraria from the NYU Medical Center, University of Pennsylvania Medical Center and University of Cincinnati for Grand and Movement Disorders Rounds; received personal compensation as a speaker for Intellyst® Medical Communication on Huntington disease and as a consultant for Scientia Advisors; and government support from Department of Veterans Affairs.